In VitroAntimalarial Activity of Different Inhibitors of the Plasmodial Isoprenoid Synthesis Pathway
Open Access
- 1 August 2015
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 59 (8) , 5084-5087
Abstract
Previous studies have shown that fosmidomycin, risedronate, and nerolidol exert antimalarial activityin vitro. We included squalestatin, an inhibitor of the isoprenoid metabolism inErwinia uredovora, and found that combinations of compounds which act on different targets of the plasmodial isoprenoid pathway possess important supra-additivity effects.Keywords
This publication has 24 references indexed in Scilit:
- Designing the next generation of medicines for malaria control and eradicationMalaria Journal, 2013
- Cloning and characterization of bifunctional enzyme farnesyl diphosphate/geranylgeranyl diphosphate synthase from Plasmodium falciparumMalaria Journal, 2013
- Inaugural meeting of the malaria policy advisory committee to the WHO: conclusions and recommendationsMalaria Journal, 2012
- Chemical Rescue of Malaria Parasites Lacking an Apicoplast Defines Organelle Function in Blood-Stage Plasmodium falciparumPLOS Biology, 2011
- In VitroandIn VivoAntiplasmodial Activities of Risedronate and Its Interference with Protein Prenylation in Plasmodium falciparumAntimicrobial Agents and Chemotherapy, 2011
- The evolution, metabolism and functions of the apicoplastPhilosophical Transactions of the Royal Society B: Biological Sciences, 2010
- Carotenoid Biosynthesis in Intraerythrocytic Stages of Plasmodium falciparumJournal of Biological Chemistry, 2009
- Terpenes Arrest Parasite Development and Inhibit Biosynthesis of Isoprenoids inPlasmodium falciparumAntimicrobial Agents and Chemotherapy, 2004
- Statistical analysis of drug-drug and site-site interactions with isobologramsLife Sciences, 1989
- Human Malaria Parasites in Continuous CultureScience, 1976